Nurix Therapeutics, Inc. Common stock (NRIX) is a publicly traded Healthcare sector company. As of August 20, 2026, NRIX trades at $27.72 with a market cap of $2.79B and a P/E ratio of -8.13. NRIX moved -0.27% today. Year to date, NRIX is +53.88%; over the trailing twelve months it is +182.42%. Its 52-week range spans $8.18 to $28.23. Analyst consensus is strong buy with an average price target of $34.25. Rallies surfaces NRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NRIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NRIX recently traded at $27.72. Market cap is $2.79B. P/E ratio is -8.13. Revenue is $36.77M.
| Metric | Value |
|---|---|
| Price | $27.72 |
| Market Cap | $2.79B |
| P/E Ratio | -8.13 |
| EPS | $-3.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.23 |
| 52-Week Low | $8.18 |
| Volume | 1.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $36.77M |
| Net Income | $-341.35M |
| Gross Margin | 0.00% |
13 analysts cover NRIX: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.25.